Voluntary Sodium Reduction Goals (Edition 2) Draft Guidance and Preliminary Assessment of Progress

  Рет қаралды 1,106

U.S. Food and Drug Administration

U.S. Food and Drug Administration

8 күн бұрын

The U.S. Food & Drug Administration (FDA) hosted a stakeholder webinar on Thursday, October 10, 2024, at 1:00 pm ET to provide an overview of the recently released draft guidance outlining new, voluntary targets for sodium reduction in foods, as well as a preliminary assessment of progress 2010-2022. The draft guidance serves as Phase II of the FDA’s stepwise sodium reduction efforts and builds on the sodium reduction goals issued in 2021, now referred to as Phase I. Phase II contains three-year sodium reduction targets for 163 food categories that are commercially processed and packaged or prepared in food service establishments such as restaurants. The targets are intended to help address the excess intake of sodium in the U.S.-which is currently almost 50 percent more on average than the recommended limit.
Draft Guidance - www.fda.gov/re...
Preliminary Assessment of Progress (2010 - 2022) - www.fda.gov/fo...
Sodium Reduction in the Food Supply - www.fda.gov/fo...

Пікірлер
FDA | NIH: Regulatory Do’s and Don'ts: Tips from FDA - CDER Segment
1:16:43
U.S. Food and Drug Administration
Рет қаралды 1,2 М.
FDA | NIH: Regulatory Do’s and Don’ts: Tips from FDA - CBER Segment
1:05:05
U.S. Food and Drug Administration
Рет қаралды 602
How to whistle ?? 😱😱
00:31
Tibo InShape
Рет қаралды 13 МЛН
Sickle Cell Disease: A Spotlight on Women
1:00:38
U.S. Food and Drug Administration
Рет қаралды 881
Clinicians Connect: Conversations with FDA's Chief Medical Officer on Overdose Prevention
57:31
Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 - Part 1
2:27:19
U.S. Food and Drug Administration
Рет қаралды 376
Biosimilars: Totality of the Evidence in Biosimilar Development
6:32
U.S. Food and Drug Administration
Рет қаралды 176
Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 - Part 2
3:10:15
U.S. Food and Drug Administration
Рет қаралды 380
FDA’s Modernized Office of the Chief Scientist
3:52
U.S. Food and Drug Administration
Рет қаралды 1,1 М.
A Walk-Through of FDA’s Purple Book: Database of Biological Products
11:06
U.S. Food and Drug Administration
Рет қаралды 85
Biosimilars: Comparative Analytical Assessment
4:39
U.S. Food and Drug Administration
Рет қаралды 123
Biosimilars: The Purple Book
5:31
U.S. Food and Drug Administration
Рет қаралды 118
STEM at CBER
4:26
U.S. Food and Drug Administration
Рет қаралды 259